TAVR: Criteria, Risks, Technology & Future (EP Video)
Dr. Lee Lucas discusses the risks and future of TAVR procedures (30:13 minutes).
You may also like
Outcomes of Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome due to COVID-19: The Lessons Learned from the First Wave of COVID-19
Extracorporeal membrane oxygenation (ECMO) has been used as a refractory treatment for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19), but there has been little evidence of its efficacy. We conducted this study to share our experience using ECMO as a bridge to recovery for ARDS due to COVID-19.
1 min read
Bedside Blood Testing Significantly Lowers Infant Mortality Following Congenital Heart Surgery
In hospitals nationwide, three out of four infants who die after undergoing high-risk congenital heart surgery could survive if doctors monitored blood […]
3 min read